Abstract Background: Emerging evidence indicates that cannabidiol (CBD) may offer meaningful therapeutic benefits across neurological, pain, and psychiatric disorders. Cannabidiol…
Abstract Cannabigerol (CBG) is a nonintoxicating phytocannabinoid gaining popularity as a self-medication for anxiety and other conditions; however, its pharmacological…
Abstract Impaired decision-making is often seen in people with bipolar disorder (BD), even those undergoing treatment. Targeted therapeutics are therefore…
Abstract Given the increasing use of cannabis in the US, there is an urgent need to better understand the drug’s…
Abstract No preclinical experimental approach enables the study of voluntary oral consumption of high-concentration Δ9-tetrahydrocannabinol (THC) and its intoxicating effects,…
Abstract There is evidence that cannabis use during adolescence leads to memory and cognitive problems in young adulthood but little…
Abstract Introduction: Few animal studies have evaluated the pharmacological effects of Δ9-tetrahydrocannabinol (THC) in relation to its pharmacokinetic properties. Understanding…
Authors: Daniele Piomelli, Susan Weiss, Graham Boyd, Rosalie Liccardo Pacula, Ziva Cooper Affiliations: Department of Anatomy and Neurobiology School of…
Abstract Dr. Igor Grant, MD, is distinguished professor and chair of psychiatry and director of the HIV Neurobehavioral Research Program…
Abstract The joint 7th European Workshop on Cannabinoid Research and IACM 8th Conference on Cannabinoids in Medicine was held in…